Hematology & Oncology
Dr. Wassim Mchayleh
Dr. Wassim Mchayleh is Medical Director of Breast Oncology at Advent Health.
Contributions & Related Content
Podcasts
ASCO 2026: First-Line ADCs in Triple-Negative Breast Cancer
ASCO 2026: SERENA-6 and Molecular Progression in ER-Positive Breast Cancer
Moving Oral SERDs into the Adjuvant Setting: Insights from the lidERA Trial with Drs. Mchayleh & Jhaveri
Drs. Wassim Mchayleh & Komal Jhaveri Discuss the evERA Trial in ER+ Metastatic Breast Cancer
Drs. Wassim Mchayleh & Komal Jhaveri: EMBER-3 Trial Insights
Dr. Wassim Mchayleh on ASCENT-03: Evaluating Sacituzumab Govitecan in Metastatic Breast Cancer
Dr. Wassim Mchayleh on TROPION-Breast02: Evaluating Dato-DxD in Metastatic Breast Cancer
Dr. Wassim Mchayleh on VIKTORIA-1: Gedatolisib Combinations in HR+/HER2- Metastatic Breast Cancer
Dr. Wassim Mchayleh on evERA: Exploring Elacestrant Combinations in ER+/HER2– Metastatic Breast Cancer
Dr. Sara Tolaney & Dr. Wassim Mchayleh on Trial Design & Patient Populations in ASCENT-03 and TROPION-Breast02
Interpreting Efficacy & Ethical Design: Drs. Tolaney and Mchayleh on ORR, PFS, OS & Crossover Strategy
Crossover & Survival Implications: Drs. Sara Tolaney and Wassim Mchayleh on ASCENT-03 vs TROPION-Breast02
Managing Challenging Toxicities: Drs. Sara Tolaney & Wassim Mchayleh on Safety Considerations for SG and Dato-DXd
Where Are We Going With ADCs in TNBC? Insights from Drs. Sara Tolaney & Wassim Mchayleh
Viktoria-1: Summary and Conclusion with Drs. Erica Mayer & Wassim Mchayleh
evERA: Overview and Practice Changing Implications with Drs. Erica Mayer & Wassim Mchayleh
